Pharmaceutical Product Supply – Tetracaine Hydrochloride

The contract pertains to the supply and delivery of Tetracaine Hydrochloride, a pharmaceutical-grade local anesthetic, in commercial form that meets strict regulatory standards including FDA approval, current Good Manufacturing Practices (cGMP), and Defense Logistics Agency (DLA) requirements. The product is intended for defense and federal agency use, with all manufacturing and delivery processes required to adhere to quality and compliance protocols ensuring safety, efficacy, and consistency. The contract is structured as a subcontract under the Department of Defense, specifically managed by the Defense Logistics Agency, and falls under the NAICS code 325412 for pharmaceutical and medicinal product manufacturing. The solicitation was posted on June 25, 2026, and is linked to the contract vehicle SPE2DX15D9383 with delivery order SPE2DP25F063D, indicating it is part of an existing federal procurement framework. There is no specified set-aside classification, suggesting the opportunity is open to all qualified vendors regardless of business size or category. While no point of contact or physical performance location is detailed, the product must be delivered to meet DLA’s distribution network needs across the United States. Compliance with all applicable federal pharmaceutical regulations is mandatory, and failure to meet these standards will result in rejection or termination of delivery obligations.